Clinical Trial: A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Neovascular Age-Related Macular Degeneration (nAMD)
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Neovascu
Brief Summary:
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Read more